NA
CLB icon

Navellier & Associates’s Core Laboratories CLB Stock Holding History

Navellier & Associates’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,706
Closed -$735K – 326
2014
Q1 		$735K Sell
3,706
-9,495
-72% -$1.79M 0.03% 122
2013
Q4 		$2.52M Buy
+13,201
New +$2.46M 0.11% 45

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Navellier & Associates's CLB Position: Q2 2014 in Review

Navellier & Associates sold out of Core Laboratories (CLB) in Q2 2014, closing a stake of 3,706 shares — an estimated $735K sold.

Navellier & Associates first reported a position in CLB in Q4 2013 and held it in 2 quarters. The position peaked at $2.52M in Q4 2013. 346 funds tracked by Wall St. Rank hold CLB as of Q2 2014.

  • Navellier & Associates reported no remaining Core Laboratories position as of Q2 2014 after selling out during the quarter.
  • Navellier & Associates sold 3,706 Core Laboratories shares in Q2 2014, an estimated $735K.
  • Navellier & Associates first reported a position in Core Laboratories in Q4 2013 and held it in 2 quarters.
  • Navellier & Associates's Core Laboratories position peaked at $2.52M in Q4 2013.
  • 346 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2014.

Based on Navellier & Associates's 13F filing for Q2 2014, filed 9 Jul 2014.